Fig. 7
The results of Molecular docking (superimposition of the best active ingredients) of key targets i.e. AKT1 (A), MAPK1 (B), MMP9 (C), NF-κB (D) and RELA (E) and specific bioactives of BME.
Fig. 7 | Scientific Reports
The results of Molecular docking (superimposition of the best active ingredients) of key targets i.e. AKT1 (A), MAPK1 (B), MMP9 (C), NF-κB (D) and RELA (E) and specific bioactives of BME.
